A day of training and discussion at the Johnson & Johnson plant in Latina
The value of innovation in pharmaceutical production and the role of young people in the medicine of the future. Yesterday, Thursday 27 February, the event was held around these topics at the Johnson & Johnson Innovative Medicine plant in Latina, with over 60 young people from the Galilei-Sani and San Benedetto high schools in Latina, who discovered the drug production process guided by company experts.
The initiative is part of the fifth edition of Fattore J, a project promoted with Johnson & Johnson to bring young people closer to the future of health, and is part of a series of initiatives promoted in the month dedicated to cancer prevention (National Cancer Prevention Month) to highlight the crucial role of innovation in the treatment and prevention of oncological diseases.
The young people of Latina have shown themselves ready to embrace innovation. According to a survey conducted by Fondazione Mondo Digitale on the participating students, in fact, medicine (72%) and scientific research (67%) will be the sectors that will benefit most from the impact of artificial intelligence, allowing healthcare to become more effective (56%), rapid (54%) and organized (54%). Also with respect to the challenges of oncology, students believe that AI will play an important role, especially in the continuous monitoring of patients in real time (48%), in prevention (41%) and in accelerating the development of new therapeutic molecules and personalized treatments (41%).
The meeting, opened by the mayor of Latina, Matilde Celentano, also included a discussion between representatives of institutions, the third sector and industry, to consider how the system can work together to ensure that young people are active agents of change in the world of health and research. Speakers included: Jorge Lopez, general manager of the Johnson & Johnson Innovative Medicine plant in Latina, Simona Mulè, councillor of the Municipality of Latina and vice-coordinator of the Women's Council of Anci Lazio, Paolo Forzan, president of the Italian Association against Leukemia, Lymphoma and Myeloma (Ail) of the Latina section, Mirta Michilli, general manager of the Fondazione Mondo Digitale ETS and Monica Gibellini, Government Affairs, Policy & Patient Engagement Director of Johnson & Johnson Innovative Medicine Italia.
The Johnson & Johnson plant in Latina is a state-of-the-art facility in the pharmaceutical sector and a pillar of the company's global supply chain. Specializing in key therapeutic areas such as oncology, neuroscience, cardiovascular and immunology, the plant has 700 employees and boasts an output of over 4 billion tablets every year, 97% of which are destined for export. Thanks to a recently announced investment of 125 million euros over the next 5 years, the plant aims to increase its production capacity by over 25%, with a concrete and positive impact on employment and competitiveness in the Lazio region. The plant has been recognized as a Lighthouse Company (i.e. one of the most innovative sites in the world with respect to Industry 4.0 requirements) by the World Economic Forum, in recognition of the company's commitment to sustainable innovation.
From learning to direct experience
One of the most engaging moments of the day was the practical activity in the classroom, during which Johnson & Johnson employees guided the students in an immersive experience, simulating the functioning of a pharmaceutical production line on a small scale. A valuable opportunity to closely observe the industrial processes of a cutting-edge plant and acquire skills that could prove decisive in their future educational and professional careers. “This approach made learning more concrete, allowing participants to directly experience the functioning of an advanced business context and develop transversal skills useful for their future,” explains Elisa Amorelli, communication and social marketing coordinator for the Fondazione Mondo Digitale.